Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial.

Wouter M SluisWilleke F WestendorpDiederik van de BeekPaul J NederkoornH Bart van der Worp

Published in: PloS one (2022)

This post-hoc analysis of PASS confirmed higher rates of pneumonia with higher ISAN scores, and suggests that in acute stroke patients with an ISAN score of ≥15, preventive ceftriaxone for four days may reduce pneumonia rate.

Keyphrases

atrial fibrillation
community acquired pneumonia
respiratory failure
clinical trial
study protocol
intensive care unit
phase ii
blood brain barrier
double blind